BIOCRYST PHARMACEUTICALS INC reports

Company location: Durham, NC
Fiscal year end: 31 December

BIOCRYST PHARMACEUTICALS INC has filed 1,958 SEC EDGAR filings since 14 Feb 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 251-275 of 1,000 matching filings.

Per page

25

Current page

11

4

PRIMARY DOCUMENT

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 000-23186

144 filing

Filing date: 15 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 000-23186

144 filing

Filing date: 14 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-23186

FORM 8-K

Filing date: 14 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-23186

10-Q

Filing date: 08 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-23186

FORM 8-K

Filing date: 03 May 2023
Reporting date: 03 May 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 000-23186

FORM ARS

Filing date: 27 Apr 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 000-23186

DEFA14A

Filing date: 27 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 000-23186

DEF 14A

Filing date: 27 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-23186

FORM 8-K

Filing date: 18 Apr 2023
Reporting date: 17 Apr 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Apr 2023
Reporting date: 03 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Mar 2023
Reporting date: 21 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-23186

FORM 8-K

Filing date: 13 Mar 2023
Reporting date: 13 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Mar 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Mar 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Mar 2023
Reporting date: 28 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .